Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly neoadjuvant paclitaxel-carboplatin followed by radical cisplatin chemoradiation for locally advanced cervical cancer
ISRCTN98873899Phase 2Completed
- Sponsor
- University College London
- Start
- Jun 2005
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel, carboplatin and cisplatin in Cervical Cancer (CC), sponsored by University College London. Primary endpoint: Overall response to neoadjuvant chemotherapy and concomitant chemoradiotherapy. Started Jun 2005; status: completed.
02
Drugs
paclitaxelcarboplatincisplatin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on ISRCTN98873899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN98873899.